Eric Lefkosky Cofounder of Tempus
Tempus is a company that offers genetic testing and aggregates clinical information. It initially focused on cancer patients and has expanded its efforts to include the rare Covid-19 virus. The company was founded in 2015 by former Lightbank co-founder Eric Lefkofsky. Tempus says it is the largest molecular library in the world.
In addition, it is the only medical technology development company in the world that has such a large data bank. Tempus is a global company that uses advanced genetic analysis to enable physicians to provide individualized cancer care. As Eric Lefkofsky points out, Tempus bills insurance companies for sequencing. It offers a service that matches patients with clinical trials. Tempus also licenses de-identified patient data to the oncology industry.
Up to now, its users are given the option to protect their privacy by opting into its services. The medical research company will only share information about the patient that has consented to share it with third parties. Eric Lefkofsky adds that Tempus’ mission is to improve patient care by providing physicians with personalized cancer treatments.
The company is developing a platform that allows doctors to use genetic information to determine what treatment will work best for their patients. The software was created to work across many types of illnesses, including major depressive disorder. As Eric Lefkofsky explains, this technology is allowing doctors to deliver better care to their patients. It has a global footprint and is rapidly expanding.